INS and Parkinson disease: Although the protective mechanisms are currently unclear (Verma and Goyal 2024), there are known roles for GLP-1 and insulin signaling in PD and other neurological disease risk (Han et al. 2023; Ruiz-Pozo et al. 2023; Zheng et al. 2024).